Q4 2022 Holdings
Filed 2023-02-14 | 28 holdings | $593.6M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2023-05-15) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $78.9M | 2,699,865 | 13.3% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $71.9M | 4,563,962 | 12.1% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $51.7M | 670,718 | 8.7% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $46.7M | 4,038,117 | 7.9% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $37.7M | 3,707,891 | 6.4% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $34.2M | 3,517,125 | 5.8% |
| Celcuity Inc(CELC) | COM | 15102K100 | $29.5M | 2,105,386 | 5.0% |
| DBV Technologies S A | SPONSORED ADR | 23306J101 | $29.3M | 9,300,000 | 4.7% |
| Dice Therapeutics Inc | COM | 23345J104 | $25.6M | 819,000 | 4.3% |
| Aerovate Therapeutics Inc | COM | 008064107 | $21.9M | 747,869 | 3.7% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $20.9M | 1,080,000 | 3.5% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $19.7M | 2,916,667 | 3.3% |
| Novavax Inc(NVAX) | COM NEW | 670002401 | $19.3M | 1,879,894 | 3.3% |
| Merus N V | COM | N5749R100 | $19.0M | 1,226,214 | 3.2% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $17.5M | 1,895,285 | 3.0% |
| Annexon Inc(ANNX) | COM | 03589W102 | $16.6M | 3,220,050 | 2.8% |
| Vectivbio Hldg AG | ORD SHS | H9060V101 | $16.2M | 1,866,000 | 2.7% |
| Provention BIO Inc(PRVBUSD) | COM | 74374N102 | $11.8M | 1,118,653 | 2.0% |
| Savara Inc(SVRA) | COM | 805111101 | $9.8M | 6,351,531 | 1.7% |
| Milestone Pharmaceuticals in(MIST) | COM | 59935V107 | $8.7M | 2,208,812 | 1.5% |
| Lianbio | SPONSORED ADS | 53000N108 | $7.9M | 4,793,047 | 1.3% |
| Marinus Pharmaceuticals Inc(MRNS*) | COM NEW | 56854Q200 | $7.0M | 1,770,705 | 1.2% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $5.9M | 3,050,022 | 1.0% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $3.3M | 447,326 | 0.5% |
| Lyra Therapeutics Inc(LYRA) | COM | 55234L105 | $2.9M | 924,170 | 0.5% |
| Inozyme Pharma Inc | COM | 45790W108 | $2.8M | 2,709,987 | 0.5% |
| Atyr Pharma Inc(ATYR) | COM NEW | 002120202 | $2.6M | 1,171,436 | 0.4% |
| Affimed N V | COM | N01045108 | $1.8M | 1,428,571 | 0.3% |
| Rallybio Corp | COM | 75120L100 | $1.8M | 268,532 | 0.3% |